A5012386908- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Advanced Radiotherapy Techniques
- Urologic and reproductive health conditions
- Urinary Bladder and Prostate Research
- Hormonal and reproductive studies
- Bladder and Urothelial Cancer Treatments
- Sexual function and dysfunction studies
- Urological Disorders and Treatments
- Genital Health and Disease
- Hepatocellular Carcinoma Treatment and Prognosis
- Effects of Radiation Exposure
- Surgical Simulation and Training
- Pelvic floor disorders treatments
- Statistical Methods in Clinical Trials
- Sexual Differentiation and Disorders
- Radiation Effects and Dosimetry
- Cancer, Lipids, and Metabolism
- Radiation Therapy and Dosimetry
- Genetic factors in colorectal cancer
- Advanced X-ray and CT Imaging
- Colorectal Cancer Screening and Detection
- Augmented Reality Applications
- Radiopharmaceutical Chemistry and Applications
- Testicular diseases and treatments
Mount Sinai Medical Center
2009-2025
Icahn School of Medicine at Mount Sinai
2016-2025
Advanced Radiation Therapy (United States)
2023-2024
Gynecologic Oncology Group
2012-2024
Stellar Science (United States)
2019-2024
Spanish Oncology Genitourinary Group
2012-2024
NYU Langone Health
2023-2024
Memorial Sloan Kettering Cancer Center
1986-2023
New York Proton Center
2010-2020
The Medical Center of Aurora
2020
Urinary retention is a frequently reported complication following radioactive seed implantation of the prostate. If refractory, post-implant transurethral prostatic resection may ultimately be required to relieve obstruction, leading an increased risk urinary incontinence. In this series incidence prolonged was determined, and effect pretreatment treatment related factors analyzed identify high patients.A total 251 patients with organ confined prostate carcinoma underwent transperineal...
No AccessJournal of UrologyClinical Urology: Original Articles1 Nov 1997LAPAROSCOPIC PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: COMPARISON OF THE EXTENDED AND MODIFIED TECHNIQUES Nelson N. Stone, Richard G. Stock, and Pamela Unger StoneNelson Stone , StockRichard Stock UngerPamela View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)64161-2AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract...
Objective To estimate the prevalence of impotence in men over 40 years age and correlate to age, geographical location, ethnicity quality life. Subjects methods While attending ‘The Prostate Cancer Awareness Week’ Madison, WI, USA, New Orleans, LA, USA York, NY, 1680 were asked complete a questionnaire regarding impotence, Results Impotence was found be significantly associated with less location but independent ethnicity. Men living Madison reported lower potency score compared Orleans...
Abstract Background A total of 10%–20% patients develop long-term toxicity following radiotherapy for prostate cancer. Identification common genetic variants associated with susceptibility to radiotoxicity might improve risk prediction and inform functional mechanistic studies. Methods We conducted an individual patient data meta-analysis six genome-wide association studies (n = 3871) in men European ancestry who underwent Radiotoxicities (increased urinary frequency, decreased stream,...
We assess erectile function after prostate brachytherapy and analyze those factors affecting potency preservation.A total of 416 patients treated from October 1990 to September 1998 with permanent radioactive seed implantation for T1 T2 cancer had assessed before treatment. Erectile was using the scoring system 0-complete inability have erections, 1-able erections but insufficient intercourse, 2-can sufficient intercourse considered suboptimal 3-has normal function. Implant dose defined as...
Interactive, transrectal, ultrasound-guided transperineal implantation is a new technique for performing permanent brachytherapy implants of the prostate. Prostate specific antigen (PSA) findings, biopsy results, and morbidity are examined to demonstrate its efficacy safety in treating early stage prostate carcinoma.Ninety-seven patients underwent classifications T1 T2 adenocarcinoma gland with median follow-up 18 months (range: 6-51 months). Seventy-nine had negative laparoscopic pelvic...